ReviewOncoimmunology2015
Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications.
Aitziber Buqué et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
63 papers cite itlatest 60 shown
this papercites it
ReviewOncoimmunology2015
Aitziber Buqué et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.